Delivery Order SPE2DB20D1004-SPE2DB25FNKVB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count) with a ceiling value of $5,275.63. This competitive, non-set-aside delivery order represents a firm fixed price transaction with an ultimate completion date of July 29, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units, with a ceiling value of $5,358.11 and a firm fixed price structure. The contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of July 25, 2025. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $6,756.65 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units. This firm fixed-price contract was competitively awarded without set-aside designation and is scheduled for completion by July 25, 2025. AmerisourceBergen will perform this delivery from its corporate headquarters in Conshohocken, Pennsylvania, where the company maintains significant pharmaceutical distribution...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,376.58 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets (30-count packaging) on August 4, 2025, with completion targeted for August 5, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count units) valued at $1,605.86. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 20, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a routine pharmaceutical supply transaction...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order contract valued at $2,132.04 by the Defense Logistics Agency (DLA) on August 12, 2025, with an ultimate completion date of August 13, 2025. The contract calls for the delivery of Dapagliflozin 10 mg tablets in a 30-count package, a generic diabetes medication. This delivery order operates under a firm fixed-price structure with no set-aside designation, indicating...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count units) valued at $15,245.22 under a firm fixed price arrangement. This competitively awarded, non-set-aside delivery order is scheduled for completion by August 27, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a continuation of the company's role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30, valued at $29,475.49 under a firm fixed-price contract. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which carries a ceiling value of $999,999,999.00 through December 2026. The award carries no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for dapagliflozin 10 mg tablets in a quantity of 30-unit packages, with a ceiling value of $5,581.69. This contract, awarded on August 7, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, and carries no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $10,115.26 to AmerisourceBergen Drug Corp for the supply of dapagliflozin 10 mg tablets in a quantity of 30s. The contract was issued on April 24, 2025, with an ultimate completion date of April 25, 2025, and utilized firm fixed-price pricing with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNKVBDelivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency for Dapagliflozin 10 mg tablets (30-count units) valued at $1,310.65, with an ultimate completion date of September 17, 2025. This competitively awarded, non-set-aside contract employs firm fixed price terms and represents a single delivery order under the company's broader pharmaceutical supply framework with DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally, including support to the Defense Health Agency and U.S. Coast Guard. The current award for Dapagliflozin—a diabetes medication—exemplifies the company's role as a critical vendor for federal medical procurement across multiple therapeutic domains, fulfilling individual medication needs as they arise through the overarching contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/16/25 |